IdentificationGeneric Name(10R)-10-formyl-5,8,10-trideazafolic acidDrugBank Accession NumberDB04264BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (10R)-10-formyl-5,8,10-trideazafolic acid (DB04264)× CloseWeightAverage: 482.4428 Monoisotopic: 482.1437637 Chemical FormulaC23H22N4O8SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUPhosphoribosylglycinamide formyltransferaseNot AvailableEscherichia coli (strain K12)AbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentGlutamic acid and derivativesAlternative ParentsStilbenes / Hippuric acids / N-acyl-alpha amino acids / Quinazolinamines / Aromatic monoterpenoids / Bicyclic monoterpenoids / Tricarboxylic acids and derivatives / Benzoyl derivatives / Aminopyrimidines and derivatives / Pyrimidones / Heteroaromatic compounds / Vinylogous amides / Amino acids / Secondary carboxylic acid amides / Carboxylic acids / Azacyclic compounds / Hydrocarbon derivatives / Primary amines / Carbonyl compounds / Organopnictogen compounds / Organic oxides


 show 11 moreSubstituentsAmine / Amino acid / Aminopyrimidine / Aromatic heteropolycyclic compound / Aromatic monoterpenoid / Azacycle / Benzamide / Benzenoid / Benzoic acid or derivatives / Benzoyl / Bicyclic monoterpenoid / Carbonyl group / Carboxamide group / Carboxylic acid / Diazanaphthalene / Glutamic acid or derivatives / Heteroaromatic compound / Hippuric acid / Hippuric acid or derivatives / Hydrocarbon derivative / Monocyclic benzene moiety / Monoterpenoid / N-acyl-alpha amino acid or derivatives / N-acyl-alpha-amino acid / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / P-cymene / Primary amine / Pyrimidine / Pyrimidone / Quinazolinamine / Quinazoline / Secondary carboxylic acid amide / Stilbene / Tricarboxylic acid or derivatives / Vinylogous amide


 show 31 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyDAOQLLQRJAXMGY-PBHICJAKSA-NInChIInChI=1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1IUPAC Name(2S)-2-({4-[(1R)-2-(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)-1-carboxyethyl]phenyl}formamido)pentanedioic acidSMILES[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H]ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound444729PubChem Substance46504612ChemSpider392574ZINCZINC000003870535PDBe LigandNHRPDB Entries1c3eClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0406 mg/mLALOGPSlogP0.35ALOGPSlogP0.77ChemaxonlogS-4.1ALOGPSpKa (Strongest Acidic)3.37ChemaxonpKa (Strongest Basic)2.91ChemaxonPhysiological Charge-3ChemaxonHydrogen Acceptor Count11ChemaxonHydrogen Donor Count6ChemaxonPolar Surface Area208.48 Å2ChemaxonRotatable Bond Count10ChemaxonRefractivity121.68 m3·mol-1ChemaxonPolarizability45.97 Å3ChemaxonNumber of Rings3ChemaxonBioavailability0ChemaxonRule of FiveNoChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.5669Blood Brain Barrier-0.5758Caco-2 permeable-0.8076P-glycoprotein substrateSubstrate0.5P-glycoprotein inhibitor INon-inhibitor0.9644P-glycoprotein inhibitor IINon-inhibitor0.987Renal organic cation transporterNon-inhibitor0.9148CYP450 2C9 substrateNon-substrate0.8098CYP450 2D6 substrateNon-substrate0.832CYP450 3A4 substrateNon-substrate0.6007CYP450 1A2 substrateNon-inhibitor0.9043CYP450 2C9 inhibitorNon-inhibitor0.9105CYP450 2D6 inhibitorNon-inhibitor0.9438CYP450 2C19 inhibitorNon-inhibitor0.9034CYP450 3A4 inhibitorNon-inhibitor0.9313CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9515Ames testNon AMES toxic0.889CarcinogenicityNon-carcinogens0.9675BiodegradationNot ready biodegradable0.8759Rat acute toxicity2.3336 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9502hERG inhibition (predictor II)Non-inhibitor0.8403  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Phosphoribosylglycinamide formyltransferaseKindProteinOrganismEscherichia coli (strain K12)Pharmacological actionUnknownGeneral FunctionPhosphoribosylglycinamide formyltransferase activitySpecific FunctionCatalyzes the transfer of a formyl group from 10-formyltetrahydrofolate to 5-phospho-ribosyl-glycinamide (GAR), producing 5-phospho-ribosyl-N-formylglycinamide (FGAR) and tetrahydrofolate.Gene NamepurNUniprot IDP08179Uniprot NamePhosphoribosylglycinamide formyltransferaseMolecular Weight23238.065 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 